Valeant Pharmaceuticals Intl Inc (VRX), Abbott Laboratories (ABT): This Pharmaceutical Stock Promises Robust Returns
The healthcare sector has always been a subject of great interest to investors and analysts alike.
Posts Tagged ‘NYSE:ABT’
Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier
A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting...
Abbott Laboratories (ABT), VIVUS, Inc. (VVUS) – It’s Official: Obesity Is a Disease
The decision wasn't without debate, though. In fact, the AMA's Council on Science and Public Health actually recommended against calling obesity a disease.
Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY): The Best Healthcare Bet
Gilead Sciences, Inc. (NASDAQ:GILD) has been one of the most prolific investments in the healthcare sector.
Abbott Loves Abbott Laboratories (ABT) Stock
Abbott Laboratories (NYSE:ABT) seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.
Medtronic, Inc. (MDT): Should You Buy This Dividend Aristocrat?
As the market becomes more volatile and high-grade dividend stocks begin to fall in price an opportunity opens up to buy those stocks at a more reasonable price than the last ...
Identifying the Biggest Gem in Antares Pharma Inc (ATRS)’s Pipeline
Following the publication of my article on the blockbuster potential of Antares Pharma Inc (NASDAQ:ATRS)'s transformational product (Otrexup), I have been inundated with reader...
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): These Companies Have a Formula for Success
As populations grow and as food safety concerns increase, parents are being very selective about the infant baby formulas they buy.
Yahoo! Inc. (YHOO), Virgin Media Inc. (VMED): Here’s What This 758% Gainer Has Been Buying
Today, let's look at investing giant Daniel Loeb, founder of the Third Point LLC hedge fund.
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): Bet Big on Boomers and Babies
With more baby boomers hitting retirement age and their babies starting families (the so-called Echo Boom) several stocks are bound to benefit.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): Tuesday’s Top Upgrades & Downgrades
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Abbott Laboratories (ABT), Celgene Corporation (CELG) & Three Pharma Companies to Buy in 2013
Currently, a majority of pharma companies are facing the issue of generic competition.
Do Hedge Funds and Insiders Love Abbott Laboratories (ABT)?
In the 21st century investor’s toolkit, there are tons of metrics investors can use to monitor Mr. Market. A pair of the best are hedge fund and insider trading movement.
General Electric Company (GE): Why This Stock Could Be a Smart Investment
Over the past few years, General Electric Company (NYSE:GE) has posted robust growth in several business divisions.
Will This Crush Medtronic, Inc. (MDT)’s Earnings?
On Tuesday, Medtronic, Inc. (NYSE:MDT) will release its latest quarterly results.
Merck & Co., Inc. (MRK), Seadrill Ltd (SDRL), Banco Santander, S.A. (ADR) (SAN): Here’s What This Big Market-Beater Has Been Buying and Selling
Today let's look at investment advisory firm Douglass Winthrop Advisors.
Abbott Laboratories (ABT), The Chubb Corporation (CB), And Three Stocks That Offer Protection From Market Tantrums
The economy is only just starting to chug along again. The situation in Europe is relatively unchanged, China is slowing down and banks are still de-leveraging.
BEAM Inc (BEAM), Abbott Laboratories (ABT): Some Investing Lessons To Pay Attention To
If I could send a message back in time to my younger self, I would only need to use four words, “Keep it simple, Stupid!” This is great advice for life in general, but especially...
VIVUS, Inc. (VVUS): You’ve Got To Spend Money To Make Money
VIVUS, Inc. (NASDAQ:VVUS) has the first part down.
Merck & Co., Inc. (MRK), Novo Nordisk A/S (ADR) (NVO): Who Should You Buy?
Recently, I have focused in on some companies that play a major role in diabetic's lives like mine.
Coinstar, Inc. (CSTR), AbbVie Inc (ABBV) & More Stocks Billionaire Ken Fisher Loves
For the past 15 years, investment guru Ken Fisher's stock picks have outperformed the overall market by more than 5% on average each year.
J.C. Penney Company, Inc. (JCP), Abbott Laboratories (ABT) & Today’s Three Worst Stocks
No matter the market, there will always be losers-a few lagging disappointments holding back a Wall Street rally or several big losers leading a bearish day.
ConocoPhillips (COP), Phillips 66 (PSX): Are These Spinoffs Investment Worthy?
There have been a number of high-profile spin-offs over the past few years.
Microsoft Corporation (MSFT) and Oracle Corporation (ORCL): Jensen Investment Hunting Technology Stocks
This Lake Oswego, OR based hedge fund seems to have a good appetite for technology stocks, with Oracle Corporation (NASDAQ:ORCL) and Microsoft Corporation (NASDAQ:MSFT) being...
Abbott Laboratories (ABT) Changes Its Focus
Abbott Laboratories (NYSE:ABT)' first-quarter earnings were boosted by its nutritional product lines, which include baby formula Similac, adult drink Ensure, and Glucerna bars...
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Merck & Co., Inc. (MRK): The Foundations of the Pharmaceutical Industry
Merck & Co., Inc. (NYSE:MRK) took its first steps toward pharmaceutical dominance on April 30, 1953, when it merged with Sharp & Dohme, a pharmaceutical manufacturer.
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
Abbott Laboratories (ABT), a Compelling Story
It has been more than a 100 days since Abbott Laboratories (NYSE:ABT) separated its research-based pharmaceutical business into a newly formed entity named AbbVie Inc (NYSE:ABBV...
Abbott Laboratories (ABT), AbbVie Inc (ABBV) & More: Did You Know That This Stock Is Half What It Had Been?
Abbott Laboratories (NYSE:ABT) stock hit a high in October of last year of 72.47, but when the new year hit, the company split in two, spinning its drug assets into AbbVie Inc...
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY) And Why Diabetes Isn’t Good for Health, But It Can Be for Your Portfolio
When I was six years old, something happened to me that I have never forgotten and will probably always live with.
AbbVie Inc (ABBV)’s First Quarter: The Full Story of Humira And The 7 Dwarfs
In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.
Abbott Laboratories (ABT), Boston Scientific Corporation (BSX), Johnson & Johnson (JNJ): Blame Obamacare for the Medical-Device Sales Slump?
Has anyone noticed a common theme among the first-quarter results for many of the big medical-device companies? In case you missed earnings announcements from Abbott Laboratories...
Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK): Can This New Drug Win Against Established Competitors?
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Abbott Laboratories (ABT): Yawn All The Way to Retirement With It
After spinning off its pharmaceutical business -- and most of its dividend, essentially -- you may think Abbott Laboratories (NYSE:ABT) is relegated to a boring medical-device...
Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT)
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Pfizer Inc. (PFE), Bristol Myers Squibb Co. (BMY), and Alzheimer’s Milkshakes: The Growth of Medical Nutrition
A milkshake is not foremost on most people’s list of treatments for the neurological disorder Alzheimer’s.
Should You Buy Abbott Laboratories (ABT)?
Abbott Laboratories (NYSE:ABT) reported its quarterly earnings on April 17.
Abbott Laboratories (ABT): Three Things You Need to Know in the Wake of Its Earnings
2013 has been a big year for Abbott Laboratories (NYSE:ABT).
Abbott Laboratories (ABT): How Will First Quarter Results Impact This Stock?
Since spinning off AbbVie Inc (NYSE:ABBV) at the beginning of the year, Abbott Laboratories (NYSE:ABT)' stock has done pretty well, rising over 13%.
Abbott Laboratories (ABT): Will This Stock Hit New Highs After Earnings?
On Wednesday, Abbott Laboratories (NYSE:ABT) will release its latest quarterly results.
Medtronic, Inc. (MDT): The One Medical Device Company Buffett Should Buy
You would think that the medical-device sector would be rife with big gainers thanks to an aging population, but it's not quite as simple as that.
Abbott Laboratories (ABT): Are Hedge Funds Right About This Stock?
Abbott Laboratories (NYSE:ABT) was in 50 hedge funds' portfolio at the end of December.
Abbott Laboratories (ABT), Stryker Corporation (SYK): Will Obamacare Cost You Your Job?
Is your job in jeopardy because of Obamacare? Staunch advocates of the Patient Protection and Affordable Care Act would say absolutely not.
Could Medtronic, Inc. (MDT), Abbott Laboratories (ABT): This Idea Cut $35 Billion from Health Care Costs?
Take $1 out of every $3 spent on health care, throw it in the garbage can -- and pretty soon those dollars add up to a big amount.
Johnson & Johnson (JNJ): Abbott Laboratories (ABT), Too Cheap to Ignore?
Looking for a cheap stock with name-brand power and a strong, diversified portfolio of products? At first glance, you couldn't do much better than Abbott Laboratories (NYSE:ABT...
Abbott Laboratories (ABT): This Company & Ache Labs: A Perfect Match?
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY), Regeneron Pharmaceuticals Inc (REGN): Is Johnson & Johnson (JNJ) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Abbott Laboratories (NYSE:ABT): Hedge Funds Are Bearish and Insiders Are Bullish, What Should You Do?
Abbott Laboratories (NYSE:ABT) was in 50 hedge funds' portfolio at the end of the fourth quarter of 2012.
Abbott Laboratories (ABT), Biogen Idec Inc. (BIIB): Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
